Clinical Trials in Dallas

Showing 9801-9820 of 17,468 trials

A Study of LY3461767 in Healthy Participants

NCT04352114

The main purpose of this study in healthy participants is to learn more about the safety of LY3461767 and any side effects that might be associated with it. The study will also measure how much LY3461767 gets into the bloodstream and how long it takes the body to get rid of it. For each participant, the study will last about 11 weeks, including screening.

Healthy

Eli Lilly and Company48 participantsStarted Jun 2020

Daytona Beach, Florida, United States • Dallas, Texas, United States • Singapore, Singapore

COMPLETED< 1 mile

Start Time Optimization of Biologics in Polyarticular JIA

NCT02593006

STOP-JIA is a PCORI funded prospective observational study which compared the clinical effectiveness and impact on patient reported outcomes of 3 Childhood Arthritis \& Rheumatology Research Alliance (CARRA) consensus derived treatment strategies (CTPs) in new-onset polyarticular JIA (pJIA) patients to answer the critical question of when is the best time to begin biologic medications to achieve the optimal clinical and patient reported outcomes. Because the CARRA Registry will be used for data collection, all patients will be enrolled in the CARRA Registry. The standard of care treatments are chosen by the treating physician and patient/caregiver and are not randomized.

Polyarticular Juvenile Rheumatoid ArthritisArthritis, Juvenile Idiopathic

Hackensack Meridian Health400 participantsStarted Nov 2015

Birmingham, Alabama, United States • Palo Alto, California, United States • San Diego, California, United States +52 more locations

A Study of LY3461767 in Healthy Participants

Start Time Optimization of Biologics in Polyarticular JIA

Find Trials by Condition in Dallas

Tanezumab and Nerve Function In Arthritis Patients

Retrospective Multi-Center Study to Compare Perioperative Outcomes for Robotic-assisted Lobectomy With Those Associated With VATS and Open Lobectomy for Lung Cancer

An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)

A Study to Assess the Effect of a Strong CYP3A Inhibitor, on Surufatinib in Healthy Subjects

Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern

Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US

Open-label Extension Study Of RN624

Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089)

Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)

A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment

A Study of Single-Dose Gabapentin in Subjects With Transient Insomnia Induced by a Sleep Phase Advance

A 28-Day Polysomnographic Study of Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance

A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance

Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole

Day and Night Closed-loop in Young People With Type 1 Diabetes

Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects

CONFORM: Rotational Fractional Resection for Submental Contouring